PMID: 6402340Mar 1, 1983Paper

Contrasting cardiovascular and respiratory responses to exercise in mitral valve and chronic obstructive pulmonary diseases

Chest
L E NeryJ A Davis

Abstract

The role of cardiovascular and pulmonary limitation in performing maximal exercise is contrasted in patients with mitral valve disease (MVD) and chronic obstructive pulmonary disease (COPD). The ventilatory (VE) gas exchange (VO2 and VCO2) and heart rate (HR) responses to an incremental cycle ergometer exercise were measured in six patients with MVD, seven patients with COPD, and six normal subjects. The VE requirement for the work (VE-VO2 relationship) was increased in both COPD and MVD groups compared with control subjects, but the breathing reserve was significantly lower in COPD (13 percent) compared with MVD (49 percent) and control groups (44 percent). In contrast, the VO2 at the anaerobic threshold was significantly lower in MVD (12.2 +/- .5 ml/kg) compared with COPD (15.7 +/- 1.2 ml/kg) and control subjects (16.6 +/- .9 ml/kg). Also, the heart rate reserve and the VO2-HR slope were significantly reduced in MVD (9 +/- 6 percent and 6.9 +/- 1.0 ml/min/beat, respectively) compared with COPD patients (44 +/- 7 percent and 2.0 ml/min/beat, respectively). Both patient groups experienced an acidosis in their terminal work rate, but the acidosis was primarily respiratory in the COPD and totally metabolic in the MVD group. These...Continue Reading

References

Sep 1, 1971·American Heart Journal·F Khaja, J O Parker
Jun 1, 1969·The American Journal of the Medical Sciences·R Gilbert, J H Auchincloss
Nov 1, 1952·Circulation·M I FERRERD W RICHARDS
Dec 1, 1964·The American Journal of Cardiology·K WASSERMAN, M B MCILROY

❮ Previous
Next ❯

Citations

Jan 1, 1988·European Journal of Applied Physiology and Occupational Physiology·S MiyoshiY Kawashima
Mar 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·A CohenA Schachner
Jul 1, 1995·Progress in Cardiovascular Diseases·M J Sullivan, M H Hawthorne
Jun 1, 1987·Journal of the American College of Cardiology·D A MorrisonM I Schwarz
Aug 6, 2002·Respiratory Physiology & Neurobiology·Duncan L Turner, D Paul Sumners
Jun 19, 1998·Journal of Cardiopulmonary Rehabilitation·M J Berry, S A Walschlager
Nov 8, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Andreas SchmidMartin H Brutsche
Aug 25, 1984·British Medical Journal·T W Evans, P Howard
Jan 14, 2003·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN American College of Chest Physicians
Jun 15, 2013·Pulmonary Medicine·Roberta P RamosJ Alberto Neder
May 6, 2014·Heart, Lung & Circulation·Wilawan ThirapatarapongMatthew N Bartels
Oct 26, 2007·Respiration; International Review of Thoracic Diseases·Sebastiaan HolverdaAnton Vonk-Noordegraaf
Jul 1, 1997·American Journal of Physical Medicine & Rehabilitation·W L HsiJ S Lai
Feb 1, 1986·Chest·R I Stewart, C M Lewis
Mar 1, 1987·Chest·J E Hansen, R Casaburi
Feb 1, 1990·Chest·W L Eschenbacher, A Mannina
Dec 1, 1990·Chest·K GowdaC G Gallagher
Sep 1, 1992·American Heart Journal·J MyersV F Froelicher
Dec 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·R S Fishman, D M Systrom
Sep 1, 1986·Pediatric Pulmonology·J E MarcotteG J Canny
Mar 5, 2003·Clinics in Sports Medicine·Jonathon Truwit
Jul 10, 2012·Respiratory Medicine·Hilary F ArmstrongMatthew N Bartels
Jul 7, 2009·Respiratory Medicine·Céline PynnaertRobert Naeije
Jul 12, 2014·Journal of cardiology·Tetsuya TaguchiMasahiko Kurabayashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.